Coronavirus disease 19 (COVID-19) is considered a multisystemic disease. Several studies have reported persistent symptoms or late-onset complications after acute COVID-19, including post-COVID-19 hematological disorders. COVID-19-induced coagulopathy, an immunothrombotic state, has been linked to thromboembolic and hemorrhagic events. Late-onset thrombocytopenia related to immune system dysregulation has also been reported as a rare manifestation post COVID-19. Close monitoring of laboratory dynamics is considered essential to identify timely abnormal values that need further investigation, providing supportive care whenever indicated. The role of hematologists is essential in terms of the multidisciplinary approach of long COVID-19. This review summarizes all the available evidence on post-acute COVID-19 hematological complications.

中文翻译：

---

COVID-19 后的迟发性血液学并发症：血液学家的一个新出现的医学问题

冠状病毒病 19 (COVID-19) 被认为是一种多系统疾病。几项研究报告了急性 COVID-19 后的持续症状或迟发性并发症，包括 COVID-19 后的血液病。COVID-19 诱导的凝血病是一种免疫血栓状态，与血栓栓塞和出血事件有关。与免疫系统失调相关的迟发性血小板减少症也被报道为 COVID-19 后的罕见表现。密切监测实验室动态对于及时发现需要进一步调查的异常值至关重要，并在需要时提供支持性护理。就长期 COVID-19 的多学科方法而言，血液学家的作用至关重要。本综述总结了所有关于急性 COVID-19 后血液学并发症的现有证据。